The global sore throat lozenges market is projected to be valued at USD 4.4 billion in 2024 and is expected to grow at a CAGR of 5.6%, reaching an estimated value of approximately USD 7.5 billion by ...
NHS England's new Pharmacy First service allows chemists to offer medicines for a handful of ailments including sore throat - but only if you fit a specific criteria.